HIGHLIGHTS
- who: Shefali Thanawala and colleagues from the Nutriventia, Inventia Healthcare Ltd, Mumbai, India have published the article: Efficacy and Safety of TurmXTRA 60N in Delayed Onset Muscle Soreness in Healthy Recreationally Active Subjects: A Randomized Double-Blind Placebo-Controlled Trial, in the Journal: Evidence-Based Complementary and Alternative Medicine of 20/05/2022
- what: This randomized controlled trial was designed to assess the efficacy, safety, and tolerability of TurmXTRA 60N (WDTE60N) compared to placebo on DOMS in recreationally active subjects. This study was conducted on 30 healthy and recreationally active individuals. In this study, assessment . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.